Studies have reported toxic effects of metformin in patients with liver disease.
PON1 is an antioxidant enzyme synthesized mainly by the liver.
We found that metformin administration increases steatosis and inflammation in PON1-deficient mice.
PON1 deficiency is associated with toxic effects of metformin in the liver.